Recordati Rare Diseases Canada Inc. announced today the Canadian product availability of ISTURISA® (osilodrostat) for the treatment of adult patients with Cushing's disease who have persistent or ...

Amy Schumer has lost a considerable amount of weight over the past few months—over 50 pounds to date—and says that her weight ...

Dechra announced earlier today that it has received approval from the FDA for its pergolide tablets (Zygolide; Dechra) to ...

Zygolide ® is a first-to-market generic, peppermint-flavored pergolide tablet, offering enhanced features for horses ...

The FDA has approved pergolide tablets (Zygolide; Dechra) for controlling clinical signs associated with pituitary pars intermedia dysfunction (PPID) in horses, also known as equine Cushing disease.

The festive period brought some unwanted post for both Sanofi and Corcept Therapeutics in the form of FDA rejections for the companies’ respective drug applications. Sanofi revealed Dec. 24 that the ...

Steven W. Bailey, known for his roles on Shonda Rhimes shows Grey’s Anatomy and Scandal, shared his congenital myasthenia ...

Amy Schumer's journey to health began after a diagnosis of Cushing syndrome in 2024, a condition that can lead to severe health issues if left untreated. This diagnosis prompted her to embark on a ...

“Sometimes, a little bit of facial hair, specifically chin hair, can be normal,” said Dr. Divya Sistla, an endocrinologist at ...

The U.S. FDA dashed hopes that Corcept Therapeutics Inc. might be able to launch its selective glucocorticoid receptor antagonist in two indications in 2026, issuing a complete response letter for ...

Corcept Therapeutics Incorporated (NASDAQ:CORT) is among the most promising growth stocks according to analysts.